The use and misuse of pressor agents.
D000316:Adrenergic alpha-Agonists / Q000494:pharmacology; D000318:Adrenergic beta-Agonists / Q000494:pharmacology; D000775:Anesthesia, Spinal; D000804:Angiotensin II / Q000494:pharmacology; D001808:Blood Vessels / Q000187:drug effects; D004298:Dopamine / Q000494:pharmacology; D004809:Ephedrine / Q000494:pharmacology; D004837:Epinephrine / Q000494:pharmacology; D005259:Felypressin / Q000494:pharmacology; D005934:Glucagon / Q000494:pharmacology; D006321:Heart / Q000187:drug effects; D006801:Humans; D007545:Isoproterenol / Q000494:pharmacology; D008616:Mephentermine / Q000494:pharmacology; D008680:Metaraminol / Q000494:pharmacology; D008694:Methamphetamine / Q000494:pharmacology; D008729:Methoxamine / Q000494:pharmacology; D009638:Norepinephrine / Q000494:pharmacology; D010656:Phenylephrine / Q000494:pharmacology; D012769:Shock / Q000188:drug therapy; D014662:Vasoconstrictor Agents / Q000494:pharmacology
D000316:Adrenergic alpha-Agonists; D000318:Adrenergic beta-Agonists; D014662:Vasoconstrictor Agents; D000804:Angiotensin II; D010656:Phenylephrine; D008694:Methamphetamine; D005259:Felypressin; D008680:Metaraminol; D005934:Glucagon; D004809:Ephedrine; D008729:Methoxamine; D007545:Isoproterenol; D008616:Mephentermine; D004298:Dopamine; D009638:Norepinephrine; D004837:Epinephrine